Inspire Medical Systems, Inc. (INSP)

Market Cap	2.61B
Revenue (ttm)	882.62M
Net Income (ttm)	44.56M
Shares Out	29.06M
EPS (ttm)	1.48
PE Ratio	60.88
Forward PE	54.82
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,391,652
Open	83.50
Previous Close	83.27
Day's Range	83.37 - 90.57
52-Week Range	70.77 - 216.01
Beta	0.77
Analysts	Buy
Price Target	139.40 (+55.11%)
Earnings Date	Nov 3, 2025

About INSP

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The comp...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 3, 2018
• Employees: 1,246
• Stock Exchange: NYSE
• Ticker Symbol: INSP
• Website: https://www.inspiresleep.com

Analyst Summary

According to 16 analysts, the average rating for INSP stock is "Buy." The 12-month stock price target is $139.4, which is an increase of 55.11% from the latest price.

Price Target

$139.4

(55.11% upside)

Analyst Consensus: Buy